Infectious Disease
>
COVID-19 Vaccine
— Preterm, COVID-exposed infants with respiratory distress had marked inflammatory responses
by
Katherine Kahn, Staff Writer, MedPage Today
January 24, 2024
New Study Finds COVID-19 Vaccine Could Help Protect Preterm Infants
Infants born to unvaccinated mothers who had COVID-19 during pregnancy were at high risk for developing neonatal respiratory distress, the longitudinal, cohort COMP study found.
The odds of developing respiratory distress were threefold higher (OR 3.06, 95% CI 1.08-10.21) in infants born to unvaccinated mothers diagnosed with COVID-19 while pregnant compared with COVID-exposed infants born to COVID-vaccinated mothers, Mary Catherine Cambou, MD, of the University of California Los Angeles (UCLA), and colleagues reported in Nature Communications.
“This was not something we were expecting to see, as none of the babies were diagnosed with COVID-19 themselves,” co-author Karin Nielsen-Saines, MD, also from UCLA, told MedPage Today in an email. “We also noted that respiratory distress was not transient and lasted several days.”
However, when pregnant participants had received at least one mRNA vaccine dose prior to SARS-CoV-2 infection, the odds of their infants developing neonatal respiratory distress dropped to 0.33 (95% CI 0.10-0.96) — a 67% decline, the authors pointed out.
Maternal COVID-19 disease severity also appeared to be associated with the incidence of neonatal respiratory distress. Thirteen percent of pregnancies met criteria for severe or critical COVID-19. Among infants with respiratory distress, 21% were born to mothers with severe or critical COVID-19, while only 6% of babies without respiratory distress were born to women with severe disease (P=0.009).
Approximately 56% of infants with respiratory distress were either late preterm or term deliveries and 44% were preterm. “We were surprised to find out that [the results] could not be explained by prematurity alone,” Nielsen-Saines said.
Notably, a proteomic subanalysis revealed that preterm infants with respiratory distress had significantly heightened inflammatory responses (OR 10.87, P=0.0036), cellular responses (OR 31.88, P=0.0002), and chemotactic responses (OR 109.7, P=0.0108), when compared with a control group of infants from healthy, unexposed pregnancies. The molecular analysis showed that a possible mechanism to explain this phenomenon is dysregulation of the airway cilia,” Nielsen-Saines said. “Another marker that was elevated was [immunoglobulin E], which is associated with inflammation and allergic responses, as in the case of reactive airway disease.”
The study followed mother-infant pairs that included 221 mothers with laboratory-confirmed SARS-CoV-2 infection during pregnancy and 227 exposed fetuses. Between April 2020 and August 2022, 199 infants were born. Seventeen percent of neonates were diagnosed with respiratory distress. In infants unexposed to COVID-19, respiratory distress typically has a much lower incidence of just 5.2% to 6.4%, and is usually more common in preterm infants with less mature lung anatomy, the authors noted.
Among pregnant individuals enrolled in the study, 68% were unvaccinated prior to infection. Severe or critical COVID-19 occurred in 16% in this group,